Skip to main content

Table 1 Baseline characteristics

From: Determining the longitudinal validity and meaningful differences in HRQL of the PedsQL™ Sickle Cell Disease Module

Patients

Overall Group

(n = 187)

Disease type

 Hgb SS

174 (93%)

 Hgb Sβo

13 (7%)

Age, mean (sd)

13.5 (4.5)

Age group

 4–11 years

74 (40%)

 12–21 years

113 (60%)

Sex

 Female

94 (50%)

Treated with hydroxyurea within 3 months prior to randomization

114 (61%)

History of acute chest syndrome

143 (76%)

Hospitalizations for a pain crisis in past 3 years

 0

16 (9%)

 1

23 (12%)

 2

25 (13%)

 3

29 (16%)

 4

17 (9%)

 5

13 (7%)

  ≥ 6

63 (34%)